KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non-Current Deferred Tax Liability (2016 - 2025)

Teva Pharmaceutical Industries (TEVA) has disclosed Non-Current Deferred Tax Liability for 16 consecutive years, with $296.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deferred Tax Liability fell 38.72% year-over-year to $296.0 million, compared with a TTM value of $296.0 million through Dec 2025, down 38.72%, and an annual FY2025 reading of $296.0 million, down 38.72% over the prior year.
  • Non-Current Deferred Tax Liability was $296.0 million for Q4 2025 at Teva Pharmaceutical Industries, down from $399.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $991.0 million in Q1 2021 and bottomed at $296.0 million in Q4 2025.
  • Average Non-Current Deferred Tax Liability over 5 years is $591.9 million, with a median of $546.0 million recorded in 2022.
  • The sharpest move saw Non-Current Deferred Tax Liability plummeted 44.73% in 2022, then grew 10.58% in 2023.
  • Year by year, Non-Current Deferred Tax Liability stood at $784.0 million in 2021, then tumbled by 30.1% to $548.0 million in 2022, then rose by 10.58% to $606.0 million in 2023, then fell by 20.3% to $483.0 million in 2024, then plummeted by 38.72% to $296.0 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for TEVA at $296.0 million in Q4 2025, $399.0 million in Q3 2025, and $440.0 million in Q2 2025.